Skip to main content
ConductScienceScienceDex

Alexandros Makriyannis

NIH Rank #5921
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Translational
  • Early Career
  • Mentor
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 6274976Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • OTHER HEALTH PROFESSIONS
  • Microbiology & Immunology
  • Pharmacology

NIH Funding · FY2024

Linked Award Amount
$1.9M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#5,921
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Alexandros Makriyannis. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Alexandros Makriyannis as a PI. Multi-PI records show the full award amount for context.

  • 5U01AA028963-05U01
    CB1 Neutral Antagonists for Alcohol Use Disorder
    Northeastern University
    $1.2M
    award amount
  • 5R01DA052271-05R01
    Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid
    Florida International University
    $370.3K
    award amount
  • 5T32DA055553-03T32
    Training Program on Development of Medications for Substance Use Disorder
    Northeastern University
    $224.7K
    award amount
  • 5P01DA009158-22P01
    Endocannabinoid Active Sites as Therapeutic Targets
    Northeastern University
    $90K
    award amount
  • 5R13DA040423-10R13
    Chemistry and Pharmacology of Drugs of Abuse Annual Symposium
    Northeastern University
    $25K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Alexandros Makriyannis as a PI.

Northeastern University
MA
$1.5M
4 grants
Florida International University
FL
$370.3K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Northeastern University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5921
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  7. 2025
    R01 Grant Holder
  8. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Alexandros Makriyannis.

Andrea Grace Hohmann
Northeastern University
3
shared awards
Carol A Paronis
Northeastern University
3
shared awards
Laura M. Bohn
Northeastern University
3
shared awards
Raymond G. Booth
Northeastern University
3
shared awards
Spyros P Nikas
Northeastern University
3
shared awards
Madepalli Krishnappa Lakshmana
Florida International University
1
shared award

Explore further

Find collaborators for Alexandros Makriyannis

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →